176 related articles for article (PubMed ID: 38564872)
1. Meta-analysis of the comparative efficacy of benzodiazepines and antidepressants for psychic versus somatic symptoms of generalized anxiety disorder.
Beyer C; Currin CB; Williams T; Stein DJ
Compr Psychiatry; 2024 Jul; 132():152479. PubMed ID: 38564872
[TBL] [Abstract][Full Text] [Related]
2. Antidepressants plus benzodiazepines for adults with major depression.
Ogawa Y; Takeshima N; Hayasaka Y; Tajika A; Watanabe N; Streiner D; Furukawa TA
Cochrane Database Syst Rev; 2019 Jun; 6(6):CD001026. PubMed ID: 31158298
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and tolerability of benzodiazepines versus antidepressants in anxiety disorders: a systematic review and meta-analysis.
Offidani E; Guidi J; Tomba E; Fava GA
Psychother Psychosom; 2013; 82(6):355-62. PubMed ID: 24061211
[TBL] [Abstract][Full Text] [Related]
4. Azapirones for generalized anxiety disorder.
Chessick CA; Allen MH; Thase M; Batista Miralha da Cunha AB; Kapczinski FF; de Lima MS; dos Santos Souza JJ
Cochrane Database Syst Rev; 2006 Jul; 2006(3):CD006115. PubMed ID: 16856115
[TBL] [Abstract][Full Text] [Related]
5. Antidepressants for generalized anxiety disorder.
Kapczinski F; Lima MS; Souza JS; Schmitt R
Cochrane Database Syst Rev; 2003; (2):CD003592. PubMed ID: 12804478
[TBL] [Abstract][Full Text] [Related]
6. Comparative efficacy of pregabalin and benzodiazepines in treating the psychic and somatic symptoms of generalized anxiety disorder.
Lydiard RB; Rickels K; Herman B; Feltner DE
Int J Neuropsychopharmacol; 2010 Mar; 13(2):229-41. PubMed ID: 19737439
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological interventions for somatoform disorders in adults.
Kleinstäuber M; Witthöft M; Steffanowski A; van Marwijk H; Hiller W; Lambert MJ
Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD010628. PubMed ID: 25379990
[TBL] [Abstract][Full Text] [Related]
8. Hydroxyzine for generalised anxiety disorder.
Guaiana G; Barbui C; Cipriani A
Cochrane Database Syst Rev; 2010 Dec; (12):CD006815. PubMed ID: 21154375
[TBL] [Abstract][Full Text] [Related]
9. Psychological therapies versus pharmacological interventions for panic disorder with or without agoraphobia in adults.
Imai H; Tajika A; Chen P; Pompoli A; Furukawa TA
Cochrane Database Syst Rev; 2016 Oct; 10(10):CD011170. PubMed ID: 27730622
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and tolerability of short-term duloxetine treatment in adults with generalized anxiety disorder: A meta-analysis.
Li X; Zhu L; Zhou C; Liu J; Du H; Wang C; Fang S
PLoS One; 2018; 13(3):e0194501. PubMed ID: 29558528
[TBL] [Abstract][Full Text] [Related]
11. A major change of prescribing pattern in absence of adequate evidence: benzodiazepines versus newer antidepressants in anxiety disorders.
Berney P; Halperin D; Tango R; Daeniker-Dayer I; Schulz P
Psychopharmacol Bull; 2008; 41(3):39-47. PubMed ID: 18779775
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological treatments in panic disorder in adults: a network meta-analysis.
Guaiana G; Meader N; Barbui C; Davies SJ; Furukawa TA; Imai H; Dias S; Caldwell DM; Koesters M; Tajika A; Bighelli I; Pompoli A; Cipriani A; Dawson S; Robertson L
Cochrane Database Syst Rev; 2023 Nov; 11(11):CD012729. PubMed ID: 38014714
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of generalized anxiety: new pharmacologic approaches].
Boulenger JP
Encephale; 1995; 21(6):459-66. PubMed ID: 8674471
[TBL] [Abstract][Full Text] [Related]
14. Pharmacotherapy of generalized anxiety disorder.
Rickels K; Rynn M
J Clin Psychiatry; 2002; 63 Suppl 14():9-16. PubMed ID: 12562113
[TBL] [Abstract][Full Text] [Related]
15. Pharmacologic treatments effective in both generalized anxiety disorder and major depressive disorder: clinical and theoretical implications.
Casacalenda N; Boulenger JP
Can J Psychiatry; 1998 Sep; 43(7):722-30. PubMed ID: 9773222
[TBL] [Abstract][Full Text] [Related]
16. Treatment of generalized anxiety disorder.
Gorman JM
J Clin Psychiatry; 2002; 63 Suppl 8():17-23. PubMed ID: 12044104
[TBL] [Abstract][Full Text] [Related]
17. Influence of covariates on heterogeneity in Hamilton Anxiety Scale ratings in placebo-controlled trials of benzodiazepines in generalized anxiety disorder: Systematic review and meta-analysis.
Gale C; Glue P; Guaiana G; Coverdale J; McMurdo M; Wilkinson S
J Psychopharmacol; 2019 May; 33(5):543-547. PubMed ID: 30676225
[TBL] [Abstract][Full Text] [Related]
18. Pooled analysis of venlafaxine XR efficacy on somatic and psychic symptoms of anxiety in patients with generalized anxiety disorder.
Meoni P; Hackett D; Lader M
Depress Anxiety; 2004; 19(2):127-32. PubMed ID: 15022148
[TBL] [Abstract][Full Text] [Related]
19. Approaches for discontinuation versus continuation of long-term antidepressant use for depressive and anxiety disorders in adults.
Van Leeuwen E; van Driel ML; Horowitz MA; Kendrick T; Donald M; De Sutter AI; Robertson L; Christiaens T
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD013495. PubMed ID: 33886130
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder: A 6-month randomized controlled trial.
Gelenberg AJ; Lydiard RB; Rudolph RL; Aguiar L; Haskins JT; Salinas E
JAMA; 2000 Jun; 283(23):3082-8. PubMed ID: 10865302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
